These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32863134)

  • 1. Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
    Calender A; Israel-Biet D; Valeyre D; Pacheco Y
    Trends Immunol; 2020 Oct; 41(10):856-859. PubMed ID: 32863134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient.
    Monneret G; de Marignan D; Coudereau R; Bernet C; Ader F; Frobert E; Gossez M; Viel S; Venet F; Wallet F
    Cell Mol Immunol; 2020 Sep; 17(9):1001-1003. PubMed ID: 32728202
    [No Abstract]   [Full Text] [Related]  

  • 3. Calling it what it is.
    Nat Genet; 2020 Apr; 52(4):355. PubMed ID: 32246133
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
    Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
    Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.
    Demaria O; Carvelli J; Batista L; Thibult ML; Morel A; André P; Morel Y; Vély F; Vivier E
    Cell Mol Immunol; 2020 Sep; 17(9):995-997. PubMed ID: 32612152
    [No Abstract]   [Full Text] [Related]  

  • 7. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From SARS to COVID-19: the Singapore journey.
    Lin RJ; Lee TH; Lye DC
    Med J Aust; 2020 Jun; 212(11):497-502.e1. PubMed ID: 32474940
    [No Abstract]   [Full Text] [Related]  

  • 9. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.
    Yeleswaram S; Smith P; Burn T; Covington M; Juvekar A; Li Y; Squier P; Langmuir P
    Clin Immunol; 2020 Sep; 218():108517. PubMed ID: 32585295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A singular view of COVID-19.
    Eisenstein M
    Nat Biotechnol; 2020 Sep; 38(9):1016-1020. PubMed ID: 32782414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

  • 13. Protecting Healthcare Workers During the Coronavirus Disease 2019 (COVID-19) Outbreak: Lessons From Taiwan's Severe Acute Respiratory Syndrome Response.
    Schwartz J; King CC; Yen MY
    Clin Infect Dis; 2020 Jul; 71(15):858-860. PubMed ID: 32166318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern?
    Monje MHG; Martínez-Fernández R
    Mov Disord; 2020 Oct; 35(10):1725. PubMed ID: 33068472
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19: Stay Cool toward Corticosteroids.
    Fujishima S
    Keio J Med; 2020 Jun; 69(2):27-29. PubMed ID: 32475851
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV.
    Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):365-367. PubMed ID: 32035811
    [No Abstract]   [Full Text] [Related]  

  • 17. The coronavirus pandemic in five powerful charts.
    Callaway E; Cyranoski D; Mallapaty S; Stoye E; Tollefson J
    Nature; 2020 Mar; 579(7800):482-483. PubMed ID: 32203366
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view.
    Shirazi FM; Banerji S; Nakhaee S; Mehrpour O
    Eur J Clin Microbiol Infect Dis; 2020 Oct; 39(10):2001-2002. PubMed ID: 32557325
    [No Abstract]   [Full Text] [Related]  

  • 19. A plea for the pathogenic role of immune complexes in severe Covid-19.
    Vuitton DA; Vuitton L; Seillès E; Galanaud P
    Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
    Theoharides TC
    Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.